On the search of new treatment strategies in patients with affective disorders Andrea SchmittPeter Falkai Editorial 25 October 2017 Pages: 709 - 710
Guideline adherence of antidepressant treatment in outpatients with major depressive disorder: a naturalistic study David P. HerzogStefanie WagnerKlaus Lieb Original Paper 18 April 2017 Pages: 711 - 721
Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance Chiara FabbriConcetta CrisafulliAlessandro Serretti Original Paper 04 March 2017 Pages: 723 - 735
Fluoxetine reverses behavior changes in socially isolated rats: role of the hippocampal GSH-dependent defense system and proinflammatory cytokines Ivana PerićAndrijana StanisavljevićDragana Filipović Original Paper 04 May 2017 Pages: 737 - 749
Prefrontal transcranial direct current stimulation (tDCS) as treatment for major depression: study design and methodology of a multicenter triple blind randomized placebo controlled trial (DepressionDC) Frank PadbergUlrike KumpfMalek Bajbouj Original Paper 28 February 2017 Pages: 751 - 766
Is prepulse modification altered by continuous theta burst stimulation? DAT1 genotype and motor threshold interact on prepulse modification following brain stimulation S. NotzonN. VennewaldP. Zwanzger Original Paper 24 March 2017 Pages: 767 - 779
Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study Laura KranasterCarolin HoyerAlexander Sartorius Original Paper 24 March 2017 Pages: 781 - 786
Polymorphism of the brain-derived neurotrophic factor and dynamics of the seizure threshold of electroconvulsive therapy C. StephaniM. ShoukierC. Wolff-Menzler Original Paper 27 October 2016 Pages: 787 - 794
Seizure threshold increases can be predicted by EEG quality in right unilateral ultrabrief ECT Verònica GálvezDusan Hadzi-PavlovicColleen K. Loo Original Paper 11 April 2017 Pages: 795 - 801
S -ketamine compared to etomidate during electroconvulsive therapy in major depression Maxim ZavorotnyyIna KlugeCarsten Konrad Original Paper 19 April 2017 Pages: 803 - 813
Lack of relationship between plasma levels of escitalopram and QTc-interval length Mar Carceller-SindreuJavier de Diego-AdeliñoEnric Álvarez Original Paper 23 January 2017 Pages: 815 - 822
Validity and clinical utility of the DSM-5 severity specifier for bulimia nervosa: results from a multisite sample of patients who received evidence-based treatment Antonios DakanalisFrancesco BartoliGiuseppe Carrà Short Communication 19 July 2016 Pages: 823 - 829